Pirfenidone

Капсулы By prescription

Immunosuppressive agent

Pirfenidone

Indications

Pirfenidone is indicated for use in adults (over 18 years of age) to treat idiopathic pulmonary fibrosis (IPF).
If there is no improvement or if you feel worse, you should see your doctor.

Contraindications

Hypersensitivity to pirfenidone; concomitant use of fluvoxamine (see Interactions); severe renal impairment (Cl creatinine <30 ml/min); end-stage renal disease requiring dialysis; severe hepatic dysfunction; end-stage liver disease; smoking; concomitant use of strong inducers of CYP1A2 isoenzyme; pregnancy; breast-feeding.

Usage

Always take the drug in full compliance with the recommendations of your doctor. If you have any doubts, consult your doctor.
Treatment with Pirfenidone should be initiated and supervised by a specialist physician experienced in the diagnosis and treatment of IPF.

The recommended daily dose is 3 capsules (801 mg) 3 times a day (2403 mg/day).
Your drug is usually prescribed in increasing doses according to the following regimen:

- for the first 7 days: 1 capsule (267 mg) 3 times a day (801 mg/day);
- from day 8 to 14: 2 capsules (534 mg) 3 times a day (1602 mg/day);
- from day 15 onwards: 3 capsules (801 mg) 3 times a day (2403 mg/day).

Your doctor may reduce your dose if you experience side effects such as GI problems, any skin reactions to sunlight, or significant changes in liver enzyme activity.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Report

Have questions? Contact Us

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.